Palisade Bio to present four PALI-2108 studies at UEG Week 2026

Verifying
  • Palisade Bio will present four PALI-2108 studies at UEG Week 2026.
  • The program includes a Phase 1b oral presentation and three moderated posters.
  • PALI-2108 is advancing into Phase 2 trials for ulcerative colitis and Crohn’s disease.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.